Postpartum-depression trial using Neuronetics' TMS device begins

08/1/2013 | (Boston)

Neuronetics has begun patient enrollment in a clinical study to test the use of its NeuroStar transcranial magnetic stimulation, or TMS, system in patients with postpartum depression. The outpatient procedure, which takes 37 minutes, was cleared by the FDA for depression patients who have failed to respond to conventional drug therapy.

View Full Article in: (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX